Heutte, Natacha <br/><br/>
Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplant.  [electronic resource] 

 -  Leukemia & lymphoma  Jul 2011 
 - 1239-48 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2011.566951  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Models, Statistical<br/>Quality of Life<br/>Rituximab<br/>Surveys and Questionnaires<br/>Time Factors<br/>Transplantation, Autologous<br/>Young Adult